Two Sigma Securities’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Two Sigma Securities's ELV Position: Q1 2026 in Review
Two Sigma Securities reduced its Elevance Health (ELV) stake by 23% in Q1 2026, selling an estimated $136K and leaving 1,367 shares worth $400K. The position accounts for 0.05% of the portfolio, ranked #581.
Two Sigma Securities first reported a position in ELV in Q3 2016 and has held it in 26 quarters since. The position peaked at $2.17M in Q3 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Two Sigma Securities held 1,367 shares of Elevance Health worth $400K as of Q1 2026.
- Two Sigma Securities sold 415 Elevance Health shares in Q1 2026, an estimated $136K.
- Elevance Health made up 0.05% of Two Sigma Securities's portfolio in Q1 2026, its #581 holding.
- Two Sigma Securities first reported a position in Elevance Health in Q3 2016 and has held it in 26 quarters since.
- Two Sigma Securities's Elevance Health position peaked at $2.17M in Q3 2024.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.